Sg Americas Securities, LLC Aclaris Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$0.92 - $1.44 $12,384 - $19,383	13,461 Added 69.45%	32,843 $41,000
Q4 2023 Jan 12, 2024	SELL	$0.64 - $6.49 $84,686 - $858,769	-132,322 Reduced 87.22%	19,382 $20,000
Q3 2023 Oct 13, 2023	BUY	$6.56 - $10.95 $166,341 - $277,659	25,357 Added 20.07%	151,704 $1.04 Million
Q2 2023 Jul 10, 2023	BUY	$7.89 - $10.64 $761,416 - $1.03 Million	96,504 Added 323.37%	126,347 $1.31 Million
Q1 2023 Apr 28, 2023	BUY	$7.07 - $17.95 $158,947 - $403,551	22,482 Added 305.42%	29,843 $241,000
Q4 2022 Feb 02, 2023	SELL	$14.33 - $18.37 $89,376 - $114,573	-6,237 Reduced 45.87%	7,361 $116,000
Q3 2022 Oct 31, 2022	BUY	$13.07 - $18.22 $177,725 - $247,755	13,598 New	13,598 $214,000
Q1 2022 Apr 29, 2022	SELL	$9.74 - $17.92 $133,233 - $245,127	-13,679 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$12.27 - $18.49 $89,975 - $135,587	-7,333 Reduced 34.9%	13,679 $199,000
Q3 2021 Nov 01, 2021	BUY	$13.38 - $18.8 $281,140 - $395,025	21,012 New	21,012 $378,000
Q2 2020 Jul 20, 2020	SELL	$1.04 - $1.73 $13,811 - $22,974	-13,280 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$0.75 - $2.18 $9,960 - $28,950	13,280 New	13,280 $14,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.